BlueRemediomics Coordinator Rob Finn from EMBL recently got interviewed by Business Insider on the topic of technology fueling biodiscovery and the race to explore more

Our team from EMBL-EBI have published a new preprint titled “Expansion of novel biosynthetic gene clusters from diverse environments using SanntiS”. This preprint represents a

A new European research project was recently launched which aims to leverage the untapped potential of marine microbial resources.